HER2-CAR T Cells in Treating Patients With Recurrent Brain or Leptomeningeal Metastases

Clinical trial NCT03696030 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03696030
Sponsor: City of Hope Medical Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Malignant Neoplasm Metastatic Malignant Neoplasm in the Brain Metastatic Malignant Neoplasm in the Leptomeninges Breast Cancer HER2-positive Breast Cancer

Start date: 2018-11-27
Primary completion: 2027-01-24
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.